ScholarIQanswers from OpenAlex

A Panel to Predict Long-term Outcome of Infliximab Therapy for Patients With Ulcerative Colitis

PaperCitations, authors & open-access status

A Panel to Predict Long-term Outcome of Infliximab Therapy for Patients With Ulcerative Colitis is a paper indexed in ScholarIQ from OpenAlex.

How many citations does A Panel to Predict Long-term Outcome of Infliximab Therapy for Patients With Ulcerative Colitis have?

ScholarIQcitation count

A Panel to Predict Long-term Outcome of Infliximab Therapy for Patients With Ulcerative Colitis has 187 citations in the OpenAlex counts ScholarIQ stores.

When was A Panel to Predict Long-term Outcome of Infliximab Therapy for Patients With Ulcerative Colitis published?

ScholarIQyear

A Panel to Predict Long-term Outcome of Infliximab Therapy for Patients With Ulcerative Colitis has 2014 year in the ScholarIQ index.

What is the open-access status of A Panel to Predict Long-term Outcome of Infliximab Therapy for Patients With Ulcerative Colitis?

ScholarIQoa status

A Panel to Predict Long-term Outcome of Infliximab Therapy for Patients With Ulcerative Colitis has bronze oa status in the ScholarIQ index.

What is the DOI of A Panel to Predict Long-term Outcome of Infliximab Therapy for Patients With Ulcerative Colitis?

ScholarIQdoi

The DOI for A Panel to Predict Long-term Outcome of Infliximab Therapy for Patients With Ulcerative Colitis is on the source record.

What is the PMID of A Panel to Predict Long-term Outcome of Infliximab Therapy for Patients With Ulcerative Colitis?

ScholarIQpmid

The PMID for A Panel to Predict Long-term Outcome of Infliximab Therapy for Patients With Ulcerative Colitis is on the source record.

What is the OpenAlex record for A Panel to Predict Long-term Outcome of Infliximab Therapy for Patients With Ulcerative Colitis?

ScholarIQopenalex

The OpenAlex for A Panel to Predict Long-term Outcome of Infliximab Therapy for Patients With Ulcerative Colitis is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial